Rice Hall James & Associates, LLC Alkermes Plc. Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 429,927 shares of ALKS stock, worth $14.9 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
429,927
Previous 451,657
4.81%
Holding current value
$14.9 Million
Previous $12.6 Million
2.19%
% of portfolio
0.75%
Previous 0.75%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$640 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$424 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$305 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$262 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.68B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...